Literature DB >> 2951430

Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and non-cytotoxic T cell lines.

L L Lanier, A M Le, A Ding, E L Evans, A M Krensky, C Clayberger, J H Phillips.   

Abstract

The Leu-19 (NKH-1) antigen is expressed on human peripheral blood NK cells and a subset of peripheral blood cytotoxic T lymphocytes that kill "NK-sensitive" tumor cell targets without major histocompatibility complex restriction. In the present study, we demonstrate that the Leu-19 (NKH-1) antigen is also expressed on most interleukin 2 (IL 2) dependent T cell lines and clones that have been maintained in long term culture. The Leu-19 (NKH-1) antigen expressed on an antigen-specific, class I directed cytotoxic T lymphocyte cell line was an approximately 200,000 to 220,000 dalton protein, similar to Leu-19 (NKH-1) protein expressed on natural killer cells and KG1a, an immature stem cell leukemia cell line. Furthermore, Leu-19 (NKH-1) was expressed on both CD4+ and CD8+ IL 2 dependent T cell clones, and was present on both cytotoxic and non-cytotoxic T cell clones. Thus expression of Leu-19 (NKH-1) antigen on cultured cell lines does not directly correlate with cytotoxic function, antigenic specificity, or cell lineage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951430

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.

Authors:  R Leo; M Boeker; D Peest; R Hein; R Bartl; J E Gessner; J Selbach; G Wacker; H Deicher
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

2.  Establishment of human T cell clones exhibiting natural killer-like activity.

Authors:  S Alam; Y Katakura; S Shirahata
Journal:  Cytotechnology       Date:  1999-09       Impact factor: 2.058

3.  Intestinal intraepithelial and splenic natural killer cell responses to eimerian infections in inbred chickens.

Authors:  H S Lillehoj
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  High endothelial venule and immunocompetent cells in typical medullary carcinoma of the breast.

Authors:  H Tanaka; M Hori; T Ohki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 5.  The development of potential antibody-based therapies for myeloma.

Authors:  Daniel W Sherbenou; Christopher R Behrens; Yang Su; Jeffrey L Wolf; Thomas G Martin; Bin Liu
Journal:  Blood Rev       Date:  2014-09-28       Impact factor: 8.250

6.  Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase.

Authors:  J Tarkkanen; E Saksela
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

7.  Expression of CD56 (NKH-1) differentiation antigen in human thyroid epithelium.

Authors:  J Zeromski; M Bagnasco; F Paolieri; G Dworacki
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

8.  Immunoelectron microscopy of acute graft versus host disease of the skin after allogeneic bone marrow transplantation.

Authors:  M Takata; T Imai; T Hirone
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

9.  Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia.

Authors:  M A Reuss-Borst; B Steinke; H D Waller; H J Bühring; C A Müller
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

10.  Interactions between interleukin-2-activated lymphocytes and vascular endothelium: binding to and migration across specialized and non-specialized endothelia.

Authors:  G Pankonin; B Reipert; A Ager
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.